Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

PPH
VanEck Vectors Pharmaceutical ETF

  • Fund Description

    VanEck Vectors Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 02/24/17

    • 30-Day SEC Yield1

      2.10%
    • Total Net Assets

      $422.3M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      03/31/2017
  • Portfolio Composition (%)
    as of 02/24/17

    • % of Net Assets
    • Stocks

      99.91
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.09
  • Download All HoldingsDaily Holdings (%) as of 02/24/17

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    355,375
    43,615,17410.33
    Novartis Ag
    NVS US
    418,458
    32,338,4347.66
    Pfizer Inc
    PFE US
    840,964
    28,811,4276.82
    Abbott Laboratories
    ABT US
    528,626
    24,147,6365.72
    Merck & Co Inc
    MRK US
    329,392
    21,792,5755.16
    Eli Lilly & Co
    LLY US
    254,269
    21,071,2724.99
    Glaxosmithkline Plc
    GSK US
    506,922
    21,067,6784.99
    Sanofi
    SNY US
    469,793
    20,060,1614.75
    Abbvie Inc
    ABBV US
    317,314
    19,702,0264.67
    Astrazeneca Plc
    AZN US
    662,740
    19,451,4194.61
    Bristol-Myers Squibb Co
    BMY US
    344,580
    19,448,0954.61
    Shire Plc
    SHPG US
    103,955
    18,846,0024.46
    Mckesson Corp
    MCK US
    120,994
    18,251,9454.32
    Zoetis Inc
    ZTS US
    334,213
    18,007,3964.26
    Novo Nordisk A/S
    NVO US
    486,696
    17,326,3784.10
    Teva Pharmaceutical Industries Ltd
    TEVA US
    485,727
    17,185,0214.07
    Mylan Nv
    MYL US
    407,410
    17,176,4064.07
    Amerisourcebergen Corp
    ABC US
    146,615
    13,512,0383.20
    Perrigo Co Plc
    PRGO US
    122,814
    10,369,1862.46
    Jazz Pharmaceuticals Plc
    JAZZ US
    37,974
    5,168,6411.22
    Valeant Pharmaceuticals International I
    VRX US
    317,491
    5,137,0041.22
    Mallinckrodt Plc
    MNK US
    75,003
    4,003,6600.95
    Gw Pharmaceuticals Plc
    GWPH US
    16,773
    2,075,4910.49
    Akorn Inc
    AKRX US
    82,098
    1,747,0450.41
    Endo International Plc
    ENDP US
    120,175
    1,580,3010.37
    Other/Cash
    --
    --
    359,4240.09
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.